ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

NCI “Much Stronger” Now, Rimer Says In Note To Staff.

September 21, 2001

NCI Posts Website Usability Research, Information Online.

January 12, 2001

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards

May 24, 1985